BIIB Biogen Inc.
BIIB Biogen Inc.
Healthcare · Drug Manufacturers - General
Market read
Scan convergence 3 scans as of 2026-08-17 3 bull converging
POC $175.89 · VWAP $174.42 · +19.9% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 related perspective
BIIB Price Structure
Loading timeframes…
Peers
Every watchlist BIIB belongs to, members best 30-day change first — BIIB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@healthcare
@ibb
@biotech-scan
Reported the quarter ending 2026-06-30: revenue $2.74B, diluted EPS $0.66, net income $98M (the desk's provider cache). Across the print the stock moved -3.0% (close before → first close after).
full note →Against street estimates
How BIIB's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about BIIB from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 42 days ago · Jul 7
- Biogen (BIIB) Stock Price, News & Analysis - MarketBeat
- Biogen Earnings Estimates, EPS & Revenue | NASDAQ:BIIB
- Biogen Inc (BIIB) Earnings, Actual EPS, EPS Estimates & Results
- Earnings call: Biogen reports progress and strategic pipeline expansion
- Biogen (BIIB) Beats on Q1 Earnings, Ends Some Research Programs — TradingView News
BIIB research tape
85 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.